Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Gashema

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
IJID Regions|June 19, 2026
Imported cases of dengue in Rwanda: A call for One Health integrated surveillance and response system for arboviral diseasesThierry Zawadi Muvunyi, Pierre Gashema, Emmanuel Kabalisa, et al.
Tropical Medicine and Infectious Disease|October 28, 2025
Gender-Associated Factors on the Occurrence and Prevalence of Zero-Dose Children in Sub-Saharan Africa: A Critical Literature ReviewGodfrey Musuka, Enos Moyo, Patrick Gad Iradukunda, et al.
The American Journal of Tropical Medicine and Hygiene|October 28, 2025
Understanding Malaria Treatment Adherence in Rwanda: Implications for Artemisinin ResistancePierre Gashema, Aileen Jordan, Eric Saramba, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Understanding Malaria Treatment Adherence in Rwanda: Implications for Artemisinin ResistancePierre Gashema, Aileen Jordan, Eric Saramba, et al.
Medrxiv : the Preprint Server for Health Sciences|January 10, 2024
Expansion of Artemisinin Partial Resistance Mutations and Lack of Histidine Rich Protein-2 and -3 Deletions in <i>Plasmodium falciparum infections</i> from Rukara, RwandaCecile Schreidah, David Giesbrecht, Pierre Gashema, et al.
Viruses|October 26, 2024
Mpox in East Africa: Learning from COVID-19 and Ebola to Strengthen Public Health ResponsesPierre Gashema, Tumusime Musafiri, Felix Ndahimana, et al.
Malaria Journal|May 16, 2024
Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, RwandaCecile Schreidah, David Giesbrecht, Pierre Gashema, et al.
The Lancet. Global Health|May 12, 2026
Rwanda's lessons for strengthening Africa's response to current Marburg virus disease outbreaksClaude Mambo Muvunyi, Pierre Gashema, Eric Seruyange, et al.
BMC Public Health|January 8, 2025
Undetectable = Untransmittable (U = U): insights from people living with HIV attending health facilities in RwandaPierre Gashema, Felix Ndahimana, Eric Saramba, et al.
Clinical Pharmacology and Therapeutics|April 14, 2026
A White Paper on Advancing Long-Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and RegulationMoherndran Archary, Robert Bies, Osei Boateng, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
IJID Regions|June 19, 2026
Imported cases of dengue in Rwanda: A call for One Health integrated surveillance and response system for arboviral diseasesThierry Zawadi Muvunyi, Pierre Gashema, Emmanuel Kabalisa, et al.
Tropical Medicine and Infectious Disease|October 28, 2025
Gender-Associated Factors on the Occurrence and Prevalence of Zero-Dose Children in Sub-Saharan Africa: A Critical Literature ReviewGodfrey Musuka, Enos Moyo, Patrick Gad Iradukunda, et al.
The American Journal of Tropical Medicine and Hygiene|October 28, 2025
Understanding Malaria Treatment Adherence in Rwanda: Implications for Artemisinin ResistancePierre Gashema, Aileen Jordan, Eric Saramba, et al.
Medrxiv : the Preprint Server for Health Sciences|August 8, 2025
Understanding Malaria Treatment Adherence in Rwanda: Implications for Artemisinin ResistancePierre Gashema, Aileen Jordan, Eric Saramba, et al.
Medrxiv : the Preprint Server for Health Sciences|January 10, 2024
Expansion of Artemisinin Partial Resistance Mutations and Lack of Histidine Rich Protein-2 and -3 Deletions in <i>Plasmodium falciparum infections</i> from Rukara, RwandaCecile Schreidah, David Giesbrecht, Pierre Gashema, et al.
Viruses|October 26, 2024
Mpox in East Africa: Learning from COVID-19 and Ebola to Strengthen Public Health ResponsesPierre Gashema, Tumusime Musafiri, Felix Ndahimana, et al.
Malaria Journal|May 16, 2024
Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, RwandaCecile Schreidah, David Giesbrecht, Pierre Gashema, et al.
The Lancet. Global Health|May 12, 2026
Rwanda's lessons for strengthening Africa's response to current Marburg virus disease outbreaksClaude Mambo Muvunyi, Pierre Gashema, Eric Seruyange, et al.
BMC Public Health|January 8, 2025
Undetectable = Untransmittable (U = U): insights from people living with HIV attending health facilities in RwandaPierre Gashema, Felix Ndahimana, Eric Saramba, et al.
Clinical Pharmacology and Therapeutics|April 14, 2026
A White Paper on Advancing Long-Acting Therapeutics for Maternal and Pediatric Health by Bridging Gaps in Clinical Research, Access and RegulationMoherndran Archary, Robert Bies, Osei Boateng, et al.
Pageof 4